The participants
Every approved drug, every device, and every advanced therapy on the market exists because participants said yes. They showed up for screening visits. They tolerated side effects. They traveled to sites in their own cities and across borders. They answered the phone when our team called. They trusted a process designed to help future patients, knowing they themselves might not benefit.
Most participants will never personally receive the therapy they helped bring to market. Most will not be publicly recognized. Many will not be compensated in proportion to the risk and time they accepted. They participate because someone, somewhere, needs the answer.
The community around them
No participant does this alone. Behind every person in a clinical trial is a site team, a study coordinator, a sponsor, a recruiter, a translator, a regulator, a patient advocate. Research is, and has always been, a collective effort that crosses cities, countries, and disciplines.
This year, the theme of
International Clinical Trials Day is Stronger Together: Advanced Therapy Clinical Trials Without Borders. Set by the
European Clinical Research Infrastructure Network (ECRIN) and co-hosted with the
Czech Clinical Research Infrastructure Network (CZECRIN), the 2026 theme highlights the global collaboration required to develop the next generation of therapies. It names what has always been true. The treatments that change lives rarely come from one country, one sponsor, or one discipline. They come from a global community choosing to work as one.
A thank you
International Clinical Trials Day belongs to the participants. It also belongs to everyone who stood beside them to make the trial possible.
To every participant who has been part of a 1nHealth study, and to every participant in every trial running today: thank you. The next generation of medicine is being built on what you have given, and on what we continue to build together.
